Pricing

Vaxxas

‌

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

Industries

Biotechnology, Health Care

Headquarters

Sydney, Australia

Employees

51-200

Links

Org chart

David Hoey

CEO

Collapse

Tom Lake

Chief Business Officer

Angus Forster

Chief Technology Officer

Michael Junger

Director - Industry And Government Relations

Charlotte Sweeney

Head of Formulation & Analytical

Deborah Pascoe, PhD

Senior Vice President, CMC Development

Doug Cubbin

Chief Financial Officer

Scott Fry

Chief Operating Officer

Kevin Black, CPA, MBA

Head, Special Projects

Michael Larcom

Senior Vice President of Quality

Board & advisors

Sarah Meibusch

Board Observer and Alternate Director

Teams

Research and Development

12 people · 0 jobs

Medical Device Engineering

10 people · 0 jobs

Management Team

5 people · 0 jobs

Engineering Team

5 people · 0 jobs

Project Management

4 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

HQ
0 people · 0 jobs

Similar companies

QuellTX

4 followers

Sutro Biopharma

3 followers

Active Motif

3 followers

Merck

282 followers

Dyno Therapeutics

4 followers

Cochlear

6 followers

Janux Therapeutics

1 follower

Prezzee

20 followers

Eikon Therapeutics

3 followers

PolyNovo Biomaterials

3 followers

Cosette Pharmaceuticals

1 follower

Explore companies